Abstract

An important worldwide health problem as the result of current lifestyle is metabolic syndrome (MS). It has been shown that MS induced by a high-calorie diet (HCD) in rats produces cognitive deterioration in the novel object recognition test (NORt) and decreases synaptic connections and dendritic order in the hippocampus and temporal cortex. However, it is unknown whether MS induced by an HCD participates in the cognitive process observed with the injection of Aβ1–42 into the hippocampus of rats as a model of Alzheimer disease (AD). The induction of MS in rats produces a deterioration in NORt; however, rats with MS injected with Aβ1–42 show a major deterioration in the cognitive process. This event could be explained by the increment in the oxidative stress in both cases studied (MS and Aβ1–42): together, the hippocampus and temporal cortex produce an enhancer effect. In the same way, we observed an increment in interleukin-1β, TNF-α, and GFAP, indicative of exacerbated inflammatory processes by the combination of MS and Aβ1–42. We can conclude that MS might play a key role in the apparition and development of cognitive disorders, including AD. We propose that metabolic theory is important to explain the apparition of cognitive diseases.

Highlights

  • Metabolic disorders such as atherosclerosis, cardiovascular disease, type 2 diabetes mellitus (T2DM), and metabolic syndrome (MS) are the result of current population lifestyle [1]; these are associated with body fat accumulation, hypertension, dyslipidemia, and hyperglycemia

  • Rats administered with the high-calorie diet (HCD) for three months showed an increase in the following zoometric parameters: body weight (18%, p = 0 0002), abdominal circumference (10%, p = 0 0002), body mass index (BMI) (34.5%, p < 0 0001), and Lee index (15%, p < 0 0001), which were significant in comparison to rats treated with NCD

  • The biochemical parameters showed the characteristics of the MS for the animals administered with HCD, showing a significant increase in Free fatty acid (FFA) (34%, p < 0 0001), triglycerides (49%, p < 0 0001), and LDL-chol (23.6%, p = 0 0001) (Table 2) and a significant decrease in the HDL-chol fraction (47%, p = 0 0002), compared to the group fed with the control diet (NCD)

Read more

Summary

Introduction

Metabolic disorders such as atherosclerosis, cardiovascular disease, type 2 diabetes mellitus (T2DM), and metabolic syndrome (MS) are the result of current population lifestyle [1]; these are associated with body fat accumulation, hypertension, dyslipidemia, and hyperglycemia. It has been shown that inflammation (peripherical or central) is associated with metabolic diseases [6]. Inflammation can induce the release of the cytokine tumor necrosis factor-alpha (TNF-α) [7], which produces insulin resistance by the inhibition of the insulin receptor tyrosine kinase activity [8]. TNF-α increases the secretion of interleukin- (IL-) 1β and IL-6, which decreases adiponectin secretion [9]. This inhibition results in a decrease in fat oxidation and an increase in inflammatory

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call